SANOFI80:BKK
SANOFI80 KTB DR
2,72 ฿
arrow_upward
+1,49%(+0,040) 1 p
15. okt, 23:30:02 GMT +7 · THB
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse SANOFI80 põhistatistika genereerimine…
Ava
2,68 ฿
Kõrge
2,74 ฿
Madal
2,68 ฿
Turu kapit.
98,00Â mld
Keskm. maht
105,74Â tuh
Maht
126,83Â tuh
52 näd kõrgeim
3,44 ฿
52 näd madalaim
2,66 ฿
Käibivad aktsiad
1,21Â mld
Töötajate arv
75Â tuh
Ava
2,68 ฿
Kõrge
2,74 ฿
Madal
2,68 ฿
Turu kapit.
98,00Â mld
Keskm. maht
105,74Â tuh
Maht
126,83Â tuh
52 näd kõrgeim
3,44 ฿
52 näd madalaim
2,66 ฿
Käibivad aktsiad
1,21Â mld
Töötajate arv
75Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo Finance
·
3 päeva eest
Recursion (RXRX) Enters New Growth Phase as Sanofi Kicks Off Drug Collab, Shares Soar
Profiil
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
Teave üksuse SANOFI80 KTB DR kohta
TegevjuhtPaul Hudson | Belén Garijo
Töötajad74,8 tuh
Asutatud1973
PeakontoridPariis, ÃŽle-de-France, Prantsusmaa
Sektor-
Veebisaitsanofi.com